Page last updated: 2024-09-04

nco 700 and Coronary Disease

nco 700 has been researched along with Coronary Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morita, M; Okaimatsuo, Y; Shin, WS; Sugimoto, T; Toyo-oka, T1
Abiko, Y; Chiba, K; Hayase, N; Ichihara, K; Parvez, H1
Fumino, H; Gotoh, Y; Hosoda, S; Kamishiro, T; Masaki, T; Toyo-oka, T1
Abiko, Y; Haga, N; Hara, A; Ishibashi, T1
Abiko, Y; Sashida, H1

Reviews

1 review(s) available for nco 700 and Coronary Disease

ArticleYear
Contribution of calcium-activated neutral protease to the degradation process of ischemic heart.
    Japanese circulation journal, 1991, Volume: 55, Issue:11

    Topics: Animals; Calpain; Coronary Disease; Dogs; Humans; Muscle Proteins; Myocardium; Piperazines; Platelet Aggregation; Protease Inhibitors; Rabbits

1991

Other Studies

4 other study(ies) available for nco 700 and Coronary Disease

ArticleYear
Effect of NCO-700, an inhibitor of protease, on lysosomal rupture in the ischemic myocardium.
    Journal of pharmaceutical sciences, 1991, Volume: 80, Issue:3

    Topics: Acetylglucosaminidase; Acid Phosphatase; Animals; Cathepsin D; Coronary Disease; In Vitro Techniques; Lysosomes; Male; Myocardium; Piperazines; Protease Inhibitors; Rats; Rats, Inbred Strains; Subcellular Fractions

1991
Temporary salvage of ischemic myocardium by the protease inhibitor bis[ethyl(2R,3R)-3-[(S)-methyl-1-[4-(2,3,4-trimethoxyphenyl-methyl) piperazin-1-ylcarbonyl]butyl-carbonyl]oxiran-2-carbo xylate]sulfate.
    Arzneimittel-Forschung, 1986, Volume: 36, Issue:4

    Topics: Animals; Cathepsin B; Cathepsins; Coronary Circulation; Coronary Disease; Creatine Kinase; Dogs; Endopeptidases; Female; Hemodynamics; In Vitro Techniques; Male; Myocardium; Necrosis; Neurons; Piperazines; Protease Inhibitors; Pulmonary Circulation; Rabbits

1986
Effect of NCO-700, an inhibitor of protease, on myocardial pH decreased by coronary occlusion in dogs.
    Pharmacology, 1985, Volume: 31, Issue:4

    Topics: Animals; Blood Pressure; Coronary Circulation; Coronary Disease; Dogs; Dose-Response Relationship, Drug; Female; Heart; Heart Rate; Hydrogen-Ion Concentration; Male; Myocardial Contraction; Piperazines; Protease Inhibitors

1985
Inhibition with NCO-700, a protease inhibitor, of degradation of cardiac myofibrillar proteins during ischemia in dogs.
    Biochemical pharmacology, 1985, Nov-01, Volume: 34, Issue:21

    Topics: Animals; Coronary Disease; Dogs; Electrophoresis, Polyacrylamide Gel; Female; Hemodynamics; Male; Muscle Proteins; Myocardium; Myofibrils; Piperazines; Protease Inhibitors

1985